Cargando…

Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial

BACKGROUND: Surgery is recommended for patients with high-risk submucosal invasive rectal cancer (SM-RC) after local resection but affects the quality of life due to stoma placement or impaired anal function; therefore, alternative treatment approaches are needed to prevent local metastasis. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noguchi, Masaaki, Shitara, Kohei, Kawazoe, Akihito, Yamamoto, Daisuke, Takii, Yasumasa, Saito, Yutaka, Sato, Toshihiko, Horimatsu, Takahiro, Ishikawa, Hideki, Ito, Yoshinori, Ito, Masaaki, Ikematsu, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086053/ https://www.ncbi.nlm.nih.gov/pubmed/33558891 http://dx.doi.org/10.1093/jjco/hyaa260

Ejemplares similares

Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)
por: Kadota, Tomohiro, et al.
Publicado: (2020)

Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy
por: AKAGI, YOSHITO, et al.
Publicado: (2013)

Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial
por: Sasaki, Takeshi, et al.
Publicado: (2017)

Next-generation sequencing and biomarkers for gastric cancer: what is the future?
por: Kawazoe, Akihito, et al.
Publicado: (2019)

Metachronous advanced neoplasia after submucosal invasive colorectal cancer resection
por: Minamide, Tatsunori, et al.
Publicado: (2021)

The New Era of Immunotherapy in Gastric Cancer
por: Takei, Shogo, et al.
Publicado: (2022)

Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
por: Kubota, Yohei, et al.
Publicado: (2022)

The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer
por: Kawaguchi, Gen, et al.
Publicado: (2015)

Optimal anastomotic technique in rectal surgery to prevent anastomotic leakage
por: Kitaguchi, Daichi, et al.
Publicado: (2023)

Neo-adjuvant chemoradiotherapy; an opportunity in sphincter preserving procedure for rectal cancer
por: Mozafar, Mohammad, et al.
Publicado: (2014)

Double Early Rectal Cancer Arising from Multiple Inflammatory Cloacogenic Polyps Resected by Endoscopic Submucosal Dissection
por: Ochiai, Yorinari, et al.
Publicado: (2020)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Efficacy of an additional flap operation in bladder-preserving surgery with radical prostatectomy and cystourethral anastomosis for rectal cancer involving the prostate
por: Noguchi, Keita, et al.
Publicado: (2017)

Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
por: Sugiura, Teiichi, et al.
Publicado: (2020)

Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2020)

Risk factors for intraoperative perforation during endoscopic submucosal dissection of superficial esophageal squamous cell carcinoma
por: Noguchi, Masaaki, et al.
Publicado: (2017)

Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment
por: Tada, Yasuko, et al.
Publicado: (2018)

Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
por: Takasu, Chie, et al.
Publicado: (2022)

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
por: Kanemitsu, Yukihide, et al.
Publicado: (2021)

Selection of Adjuvant Treatment Without Neoadjuvant Chemoradiotherapy for Patients With Rectal Cancer: Room for Further Investigation
por: Park, In Ja
Publicado: (2018)

Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer
por: Bando, Hideaki, et al.
Publicado: (2022)

Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer
por: Matsumoto, Hiroshi, et al.
Publicado: (2018)

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
por: Okunaka, Mashiro, et al.
Publicado: (2020)

MRI Findings of Rectal Submucosal Tumors
por: Kim, Honsoul, et al.
Publicado: (2011)

An Unusual Case of Rectal Submucosal Tumor
por: Hamada, Yasuhiko, et al.
Publicado: (2019)

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
por: Matsumoto, Hiroshi, et al.
Publicado: (2018)

Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
por: Kawazoe, Akihito, et al.
Publicado: (2020)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

Magnifying endoscopy with narrow-band imaging and salvage endoscopic submucosal dissection of a locally advanced rectal adenocarcinoma after neoadjuvant chemoradiotherapy
por: Li, Weiguang, et al.
Publicado: (2023)

Adjuvant chemotherapy in locally advanced rectal cancer after neo-adjuvant concurrent chemoradiotherapy and surgery: A retrospective study in Vietnamese patients
por: Tran, Thang, et al.
Publicado: (2023)

Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach
por: Suzuki, Gen, et al.
Publicado: (2018)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

Rectal GIST Presenting as a Submucosal Calculus
por: Testroote, Mark, et al.
Publicado: (2007)

Prolapsed rectal submucosal hematoma in pediatric case
por: Khandare, Kiran, et al.
Publicado: (2020)

A Novel Case of Functional Gastric Neuroendocrine Carcinoma Occurred after Endoscopic Submucosal Dissection
por: Shibata, Yoshiaki, et al.
Publicado: (2013)

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
por: Mishima, Saori, et al.
Publicado: (2019)

Genomic Profiling of Submucosal-Invasive Gastric Cancer by Array-Based Comparative Genomic Hybridization
por: Kuroda, Akiko, et al.
Publicado: (2011)

Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer
por: Jeong, Jae-Uk, et al.
Publicado: (2016)

Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy
por: Zhang, Hang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5fh16m5li9k98664e6bgvu6m0